BREVICON 28-DAY (ETHINYL ESTRADIOL; NORETHINDRONE) — FDA Approval NDA017743 (ALLERGAN)
BREVICON 28-DAY (ETHINYL ESTRADIOL; NORETHINDRONE) — FDA Approval NDA017743 (ALLERGAN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BREVICON 28-DAY; Active ingredients: ETHINYL ESTRADIOL; NORETHINDRONE; Application number: NDA017743.
| Brand name | BREVICON 28-DAY |
|---|---|
| Active ingredients | ETHINYL ESTRADIOL; NORETHINDRONE |
| Application number | NDA017743 |
| Sponsor | ALLERGAN |
| Dosage form | TABLET |
| Route | ORAL-28 |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19760329 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →